PRELUDE CAPITAL MANAGEMENT, LLC - QIAGEN NV ownership

QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 277 filers reported holding QIAGEN NV in Q2 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of QIAGEN NV
ValueSharesWeighting
Q3 2022$255,000
-76.4%
6,180
-73.0%
0.01%
-71.0%
Q2 2022$1,081,000
+271.5%
22,913
+336.9%
0.03%
+342.9%
Q4 2021$291,000
+1.4%
5,244
-11.0%
0.01%0.0%
Q1 2021$287,000
+4000.0%
5,891
+4538.6%
0.01%
Q3 2020$7,000
-97.7%
127
-98.3%
0.00%
-100.0%
Q2 2020$311,000
+740.5%
7,259
+706.6%
0.02%
+750.0%
Q1 2020$37,000
-97.5%
900
-98.0%
0.00%
-96.5%
Q4 2019$1,506,000
+439.8%
44,585
+402.5%
0.06%
+128.0%
Q3 2017$279,000
+9.0%
8,873
+16.1%
0.02%
+4.2%
Q2 2017$256,000
+18.5%
7,640
+2.7%
0.02%
+14.3%
Q1 2017$216,0007,4400.02%
Other shareholders
QIAGEN NV shareholders Q2 2020
NameSharesValueWeighting ↓
Hardman Johnston Global Advisors LLC 4,177,260$158,235,0006.82%
Exane Asset Management 522,037$19,742,931,0006.18%
Tikvah Management LLC 442,942$16,779,0005.01%
Opus Point Partners Management, LLC 31,620$1,198,0002.86%
EDMOND DE ROTHSCHILD HOLDING S.A. 2,600,672$98,144,0002.79%
RTW INVESTMENTS, LP 775,324$29,369,0001.76%
SANDLER CAPITAL MANAGEMENT 787,529$29,832,0001.51%
FRIESS ASSOCIATES LLC 531,900$20,148,0001.40%
Sivik Global Healthcare LLC 85,000$3,220,0001.15%
Parametrica Management Ltd 11,940$452,0000.99%
View complete list of QIAGEN NV shareholders